In order to offer readers with up-to-date information about the latest advancements in the global radiotherapy devices market, the report provides updates about market opportunities, which can benefit leading manufacturers of radiotherapy devices. With continuous evolution of the healthcare
sector, keeping a record of latest developments and trends is fundamental for radiotherapy devices manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, safety regulations, pricing analysis, list of distributors, and cost structure are provided in this section.
With massive rise in cancer prevalence, radiotherapy remains a first line therapy to arrest cancer progress. On the back of increased application of radiotherapy in cancer treatment, radiotherapy devices market is likely to remain agile. Further, an exponential spike in cancer instances coupled with technological sophistication in radiotherapy are likely to reflect favorably on the growth curve of radiotherapy devices market.
With devastating impacts on the lives of cancer patients, healthcare industry is poised to advance therapeutics as well as post treatment experiences of cancer patients. Popular treatment means such as chemotherapy render massive side effects amongst patients which often are irreversible. Turning towards radiotherapy as an alternative to chemotherapy has attained tremendous momentum in recent years.
Get sample of this report at
In this light, leading proton therapy service provider Proton Partners International has affirmed its acquisition deal of Elekta's MR-linac systems. Elekta is renowned for its radiation therapy devices. The collaboration is expected to diversify offerings in radiation therapy thereby accelerating substantial progress in radiation devices market in foreseeable future.
High Demand for Linear Accelerator Devices
With continued advancements in medical technology, linear accelerator devices have emerged to become top-selling products in the global market for radiotherapy devices. Viewed as the most-advanced radiotherapy devices, linear accelerators produce radiation and deliver it precisely in critical procedures such as intensity modulated radiation therapy and intraoperative radiation therapy. In 2017, more than US$ 2 Bn worth of linear accelerators are expected to be sold in the global radiotherapy device market.
The report aims to offer readers with ample competitive advantage and cues on market entry barriers, based on which aspiring market entrants as well as established players can drive profitable investment discretion. To aid readers’ understanding the report is systematically classified into detailed chapters. In its trailing sections the report also includes a detailed chapter on segmental analysis of radiotherapy devices market to offer veritable insights on segments’ historical and future growth estimations. Further in the course of the report readers are also enlightened about regional assessment of pivotal factors. The report also entails a country-wise assessment and forecast estimations for radiotherapy devices market.
Browse Full Report with ToC
Detailed overview of radiotherapy devices market spectrum presented in the report banks upon a robust research methodology comprising primary and secondary researches that divulge relevant and timely market intelligence figures. Voluminous information recorded in the report with the aid of these research approaches have been meticulously validated by in-house research analysts.
Radiotherapy Devices Market: Competition Landscape
This section of the report offers a detailed section on key contributors in radiotherapy devices market. A dashboard view of each of the mentioned profiles complete with detailed insights on their respective SWOT analysis along with detailed assessment of their product portfolio, market contribution, as well as recent developments have been slated to aid readers’ understanding about the competition spectrum.
Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay, Inc., GE Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, AngioDynamics, Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, and Neusoft Medical Systems Co., Ltd. are key companies that are expected to remain active in the expansion of global radiotherapy devices market through 2022.
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Adoption of Radiotherapy as a Potent Alternative to Chemotherapy Translates Growth in Radiotherapy D
Contact Name: Fact Market Research
Contact Email: email@example.com
Contact Email: firstname.lastname@example.org